期刊文献+

髓系/自然杀伤细胞祖细胞急性白血病一例并文献复习 被引量:1

原文传递
导出
摘要 目的 提高对髓系/自然杀伤细胞祖细胞(M/NKP)急性白血病的认识.方法 报告1例新近诊断的M/NKP急性白血病及其治疗经过并进行文献复习.结果 经联合化疗未达完全缓解,死于脑出血.结论 M/NKP急性白血病是一种罕见的白血病,有特异的免疫表型特征,临床进展迅速,对现行治疗不敏感,预后差.
出处 《白血病.淋巴瘤》 CAS 2010年第6期366-368,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献13

  • 1Suzuki R,Yamamoto K,Seto M,et al.CD+7 and CD+56 myeloid/natural killer cell precursor acute leukemia:a distinct hematolymphoid disease entity.Blood,1997,90:2417-2428.
  • 2Oshimi K.Progress in understanding and managing natural killer-cell malignancies.Br J Haematol,2007,139:532-544.
  • 3Ogura K,Kimura F,Kobayashi S,et al.Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.Leuk Res,2006,30:761-763.
  • 4Tezuka K,Nakayama H,Honda K,et al.Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.Int J Hematol,2002,75:201-206.
  • 5Papadaki HA,Kosteas T,Gemetzi C,et al.Acute myeloid/NK precursor cell leukemia with trisomy 4 and a novel point mutation in the extracellular domain of the G-CSF receptor in a patient with chronic idiopathic neutropenia.Ann Hematol,2004,83:345-348.
  • 6Chen VM,Mcllroy K,Loui JP,et al.Extramedullary presentation of acute leukaemia:a case of myeloid/natural killer cell precursor leukaemia.Pathology,2003,35:325-329.
  • 7Dincol G,Paland u z S,Nalcaci M,et al.Myeloid/natural killer cell precursor acute leukemia with tetraploidy.Cancer Genet Cytogene,2005,163:156-159.
  • 8Abdelhaleem M,Shago M,Sayeh E,et al.Childhood myeloid/natural killer precursor acute leukemia with novel chromosomal aberrations der (5)t (4;5)(q31;q31.3) and t (14;17)(q32;q23).Cancer Genet Cytoeenet,2007,178:141-143.
  • 9张莉,王世宏,李睿,宫本法,王慧君,郝玉书,肖志坚.髓系/自然杀伤细胞祖细胞急性白血病(附1例报道并文献复习)[J].白血病.淋巴瘤,2004,13(6):326-329. 被引量:6
  • 10冯颖倩,左学兰,张克俭,周颖,李瑞芳.髓系/NK前体细胞急性白血病1例并文献复习[J].内科急危重症杂志,2007,13(4):144-146. 被引量:2

二级参考文献24

  • 1承璐雅,王伟光,庄静丽,邹善华.CD7^+急性髓细胞性白血病临床及实验室特征分析[J].内科急危重症杂志,2006,12(2):85-86. 被引量:9
  • 2Tezuka K, Nakayama H, Honda K, et al. Treatment of a child with myeloid/N K cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation[J]. Int J Hematol, 2002, 75:201-206.
  • 3Scott A A, Head D R, Kopecky K J, et al. HLA-DR-, CD33+, CD56+,CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as FrenchAmerican-British acute myeloid leukemia-M3[J]. Blood, 1994,
  • 4Shimamoto T, Nakajima A, Katagiri T, et al. Myeloid/natural killer cell precursor acute leukemia accompanied by homozygous protein C deficiency[J]. Int J Hematol, 2003, 78:149-153.
  • 5Handa H, Motohashi S, Isozumi K, et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside[J]. Acta Haematol, 2002, 108:47-52.
  • 6Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD+56 myeloid/natural killer cell precursoracute leukemia: a distinct hematolymphoid disease entity[J]. Blood, 1997,90: 2417-2428.
  • 7Dubois S, Etzell J E, Matthay K K, et al. Pediatric acute blastic natural killer cell leukaemia[J]. Leuk Lymphoma, 2002,43:901-906.
  • 8Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells[J]. Leukemia, 2004, 18:763-770.
  • 9Suzuki R, Murata M, Kami M,et al. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0[J]. Int J Hematol, 2003, 77:482-489.
  • 10Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia[J]. Leuk Res, 1999,23:615-624.

共引文献6

同被引文献8

  • 1张莉,王世宏,李睿,宫本法,王慧君,郝玉书,肖志坚.髓系/自然杀伤细胞祖细胞急性白血病(附1例报道并文献复习)[J].白血病.淋巴瘤,2004,13(6):326-329. 被引量:6
  • 2Wada H, Masuda K, Satoh R, et al. Adult T-cell progenitors retainmyeloid potential [ J ]. Nature, 2008, 452 (7188 ) : 768-772.
  • 3Suzuki R, Yamamoto K, Seto M,et al. CD7+ and CD56+ myeloid /natural killer cell precursor acute leukemia : a distincthematolymphoid disease entity [ J ]. Blood, 1997,90(6): 2417-2428.
  • 4Suzuki R, Murata M, Kami M, et al. Prognostic significance ofCD7+CD56+ phenotype and chromosome 5 abnormalities for acutemyeloid leukemia MO [ J ]. Int J Hematol, 2003,77 ( 5 ) ; 482-489.
  • 5Morimoto M, Kondoh K, Keino D, et al. A child with myeloid /natural killer cell precursor acute leukemia treated successfully withacute myeloid leukemia-oriented chemotherapy incorporating L-asparaginase [ J ] . Leuk Res, 2010,34( 12): 1677-1679.
  • 6Suzuki R, Suzumiya J, Nakamura S, et al. Hematopoietic stem celltransplantation for natural killer-cell lineage neoplasms [ J ]. BoneMarrow Transplant, 2006, 37(4) : 425-431.
  • 7Scott AA, Head DR, Kopecky KJ, et al. HLA-DR-, CD33+,CD56+, CD16- myeloid / natural killer cell acute leukemia: apreviously unrecognized form of acute leukemia potentiallymisdiagnosed as French-American-British acute myeloid leukemia-M3[J]. Blood, 1994, 84(1 ): 244-255.
  • 8Chen L, Yin Q, Mi R, et al. CHAG priming regimen containing ofcytarabine,aclacinomycin homoharringtonine and G-CSF for relapsedrefractory acute myelogenous leukemia: a modified combinationchemotherapeutic combination [J]. Leuk Lymphoma, 2013,54(10): 2291-2293.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部